Arcutis Biotherapeutics annual gross profit
2021
2022
2023
2024
2025
Arcutis Biotherapeutics Gross Profit Growth & History (ARQT)
Arcutis Biotherapeutics's gross profit was $335.4M for fiscal 2025.
View full Arcutis Biotherapeutics company overviewArcutis Biotherapeutics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $335.4M | $188.0M | +127.51% |
| 2024 | 2024-12-31 | $147.4M | $123.2M | +509.17% |
| 2023 | 2023-12-31 | $24.2M | $21.3M | +725.34% |
| 2022 | 2022-12-31 | $2.9M | $2.9M | — |
| 2021 | 2021-12-31 | $0 | — | — |
Arcutis Biotherapeutics quarterly gross profit
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $118.9M | $44.9M | +60.68% |
| Q1 2026 | 2026-03-31 | $95.6M | $40.6M | +73.79% |
| Q4 2025 | 2025-12-31 | $115.8M | $53.4M | +85.44% |
| Q3 2025 | 2025-09-30 | $90.5M | $51.3M | +130.65% |
| Q2 2025 | 2025-06-30 | $74.0M | $46.6M | +170.18% |
| Q1 2025 | 2025-03-31 | $55.0M | $36.7M | +200.42% |
| Q4 2024 | 2024-12-31 | $62.5M | $51.2M | +453.68% |
| Q3 2024 | 2024-09-30 | $39.3M | $32.3M | +466.65% |
| Q2 2024 | 2024-06-30 | $27.4M | $23.4M | +585.88% |
| Q1 2024 | 2024-03-31 | $18.3M | $16.3M | +816.57% |
| Q4 2023 | 2023-12-31 | $11.3M | — | — |
| Q3 2023 | 2023-09-30 | $6.9M | — | — |
| Q2 2023 | 2023-06-30 | $4.0M | — | — |
| Q1 2023 | 2023-03-31 | $2.0M | — | — |
Arcutis Biotherapeutics gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, Arcutis Biotherapeutics's gross profit increased from $0 to $335.4M, a change of $335.4M. The latest reported quarter, Q2 2026, shows $118.9M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Arcutis Biotherapeutics source filings ↗